These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
649 related items for PubMed ID: 18076340
1. Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient. Lessard A, Maltais F, Boulet LP. Expert Opin Pharmacother; 2008 Jan; 9(1):83-93. PubMed ID: 18076340 [Abstract] [Full Text] [Related]
2. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics]. Jahnz-Rózyk K. Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004 [Abstract] [Full Text] [Related]
3. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. Chron Respir Dis; 2008 May; 5(4):205-9. PubMed ID: 19029231 [Abstract] [Full Text] [Related]
4. [Chronic obstructive pulmonary disease]. Holzgrabe U, Muth M. Med Monatsschr Pharm; 2007 May; 30(5):168-76; quiz 177-8. PubMed ID: 17526393 [Abstract] [Full Text] [Related]
5. Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins? Walsh GM. Trends Pharmacol Sci; 2008 Jan; 29(1):6-11. PubMed ID: 18054798 [Abstract] [Full Text] [Related]
6. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Tamura G, Ohta K. Respir Med; 2007 Sep; 101(9):1895-902. PubMed ID: 17587559 [Abstract] [Full Text] [Related]
7. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy. Onoue S, Misaka S, Kawabata Y, Yamada S. Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334 [Abstract] [Full Text] [Related]
8. Ability to control persistent asthma in obese versus non-obese children enrolled in an asthma-specific disease management program (breathmobile). Kwong KY, Rhandhawa I, Saxena J, Morphew T, Jones CA. J Asthma; 2006 Nov; 43(9):661-6. PubMed ID: 17092846 [Abstract] [Full Text] [Related]
10. Pharmacological treatment in asthma and COPD. Hoshino T, Toda R, Aizawa H. Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978 [Abstract] [Full Text] [Related]
11. Effect of obesity on clinical presentation and response to treatment in asthma. Dixon AE, Shade DM, Cohen RI, Skloot GS, Holbrook JT, Smith LJ, Lima JJ, Allayee H, Irvin CG, Wise RA, American Lung Association-Asthma Clinical Research Centers. J Asthma; 2006 Sep; 43(7):553-8. PubMed ID: 16939998 [Abstract] [Full Text] [Related]
12. Animal models of asthma: innovative methods of lung research and new pharmacological targets. Braun A, Tschernig T. Exp Toxicol Pathol; 2006 Jun; 57 Suppl 2():3-4. PubMed ID: 16584873 [Abstract] [Full Text] [Related]
14. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm. Gordon E, Lazarus SC. J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979 [Abstract] [Full Text] [Related]
15. [Chronic obstructive pulmonary disease phenotypes and the related characteristics of treatment response]. Pan MM, Sun TY, Wang C. Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):293-6. PubMed ID: 23945345 [No Abstract] [Full Text] [Related]
17. New and existing pharmacotherapeutic options for persistent asthma and COPD. Diamant Z, Tarasevych S, Clarke GW. Neth J Med; 2011 Jul; 69(11):486-99. PubMed ID: 22173362 [Abstract] [Full Text] [Related]
18. The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives. Ambrosino N, Paggiaro P. Expert Rev Respir Med; 2012 Feb; 6(1):117-27. PubMed ID: 22283584 [Abstract] [Full Text] [Related]
19. Importance of inhaler devices in the management of airway disease. Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenberg J, Barnes PJ. Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402 [Abstract] [Full Text] [Related]